CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies The Prevalence of Myocardial Bridging Associated with Coronary Endothelial Dysfunction in Patients with Chest Pain and Non-Obstructive Coronary Artery Disease Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) When, where, and how to target vascular inflammation in the post-CANTOS era? Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Original Research2021;4(3):e213296.

JOURNAL:JAMA Netw Open. Article Link

Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement

Guy Witberg, Tali Steinmetz, Uri Landes et al. Keywords: kidney injury; TAVR; clinical outcome

Full Text PDF